Search results
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 3 hours agoThe team followed up with the participants for one year, during which participants periodically donated blood to test for immune response to the vaccine: antibodies, memory ...
...WHO) Statement on the Antigen Composition of COVID-19 Vaccines - SARS-CoV-2 Continues to...
Sierra Sun Times· 2 days agoSARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein. The objective of an ...
Scientists report longest known ‘extreme’ Covid infection in 72-year-old man
The Independent via Yahoo News· 6 days agoHe was then treated with the anti-SARS-CoV-2 directed antibody sotrovimab, the anti-IL6 antibody
Engineers muffle invading pathogens with a 'molecular mask'
Phys.org· 6 days agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
Antibiotic neomycin may protect against the flu, COVID-19
Medical News Today· 4 days agoViral respiratory infections are common and generally result in a few days of illness from which...
WHO COVID vaccine advisers recommend switch to JN.1 strain
Center for Infectious Disease Research and Policy· 24 hours agoThe World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition, which...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 5 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 2 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 6 days agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also C. difficile, hepatitis ...
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel...
Morningstar· 5 days agoVILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely targets disease biology, today announced the publication of a new study in Science that validates ...